Valuation
- Market cap
- 49,002,000
- Revenue TTM
- $11,270,000
- Net income TTM
- $-10,110,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -89.71%
- Debt to equity
- 0.00
Trading
- Volume
- 223,000
- Avg volume
- 272,410
- Day's range
- $0.96 – $1.03
- Shares out
- 47,575,000
- Stochastic %K
- 25%
- Beta
- 0.79
- Analysts
- Moderate Buy
- Price target
- $4.33
Company profile
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company is headquartered in Austin, Texas.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 800 620 4187
- Website
- https://www.mindwalkai.com
- Address
- Industrious 823 Congress Ave, Suite 300, Austin, United States
Latest news
No headlines yet.
